A Study to Evaluate GSK1325760A - a Long-Term Extension Study

NCT00554619 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension
Hypertension, Pulmonary

Interventions

DRUG: GSK1325760A

Sponsor

GlaxoSmithKline